Gilead Sciences (United States)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
61%
Total
Publications
5K
Total Open
Publications
3.1K
Total
Citations
233K
Open Access
Percentage
61%
Total
Publications
5K
Total Open
Publications
3.1K
Total
Citations
233K
Breakdown
Publisher Open
23%
Both
26%
Other Platform Open
12%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
695
Hybrid 31%
752
No Guarantees 41%
1K
Other Platform Open
Domain 87%
1.7K
Institution 25%
482
Other Internet 9%
165
Public 7%
142
Preprint 6%
106
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.7K |
Europe PMC | Domain | 987 |
Semantic Scholar | Public | 115 |
DOI | Other Internet | 80 |
California Digital Library - eScholarship | Other Internet | 62 |
University of California - eScholarship University of California | Institution | 59 |
University College London - UCL Discovery | Institution | 58 |
bioRxiv | Preprint | 52 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 51 |
Figshare | Public | 34 |